HMGA2 and breast carcinoma: While an analysis of 1,097 breast cancer samples in the TCGA data set did not identify HMGA2 as a significant prognostic marker in breast cancer overall (47), its expression is predictive of relapse-free survival and metastasis in patients with TNBC (48).